Market Cap 249.91M
Revenue (ttm) 0.00
Net Income (ttm) -36.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,100,100
Avg Vol 1,361,636
Day's Range N/A - N/A
Shares Out 91.88M
Stochastic %K 31%
Beta 1.82
Analysts Strong Sell
Price Target $6.00

Company Profile

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 201...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 225 7416
Address:
2001 Market Street, Suite 3915 Unit #15, Philadelphia, United States
AStrokeOfLuck
AStrokeOfLuck Apr. 2 at 3:50 PM
0 · Reply
notreload_ai
notreload_ai Apr. 2 at 2:11 PM
$CNTX CTIM-76 wins FDA Fast Track Designation for platinum-resistant ovarian cancer. Phase 1a trial ongoing with interim data expected in June 2026. https://notreload.xyz/xy/ctim-76-receives-fda-fast-track-for-ovarian-cancer/
0 · Reply
LabPsycho
LabPsycho Apr. 2 at 2:10 PM
$CNTX People should be amazed by the prescient post below....
0 · Reply
StockConsultant
StockConsultant Apr. 2 at 11:36 AM
$CNTX Context Therapeutics stock watch, nice trend with a pullback to 2.59 support area and bullish indicators
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 2 at 11:30 AM
$CNTX Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
0 · Reply
Fantastiqo
Fantastiqo Mar. 31 at 11:21 PM
$CNTX and $AEC this two been moving under the radar.
0 · Reply
hugoraciel
hugoraciel Mar. 31 at 1:01 AM
$CNTX Analyst coverage is mixed — one Strong Buy, seven Buy and one Sell — yielding a MarketBeat average rating of "Moderate Buy" and an average price target of $6.60, with select firms (Piper Sandler, Guggenheim) raising targets into the $5$7 range. So one fkn guys says SELLS and people panic? There 8 others that are saying to BUY!!!!
0 · Reply
Okaldirimj
Okaldirimj Mar. 31 at 1:00 AM
0 · Reply
hugoraciel
hugoraciel Mar. 31 at 12:59 AM
$CNTX did i fkn miss something today for the 11% fkn nose dive?
0 · Reply
elmono
elmono Mar. 30 at 8:53 PM
$CNTX I’ll be waiting a bit longer…new target 1.5 if we lose 2.3…..
1 · Reply
Latest News on CNTX
Context Therapeutics: Undervalued Cancer Fighter

Jun 10, 2025, 7:10 AM EDT - 10 months ago

Context Therapeutics: Undervalued Cancer Fighter


Context Therapeutics Announces Chief Medical Officer Transition

May 5, 2025, 4:05 PM EDT - 11 months ago

Context Therapeutics Announces Chief Medical Officer Transition


AStrokeOfLuck
AStrokeOfLuck Apr. 2 at 3:50 PM
0 · Reply
notreload_ai
notreload_ai Apr. 2 at 2:11 PM
$CNTX CTIM-76 wins FDA Fast Track Designation for platinum-resistant ovarian cancer. Phase 1a trial ongoing with interim data expected in June 2026. https://notreload.xyz/xy/ctim-76-receives-fda-fast-track-for-ovarian-cancer/
0 · Reply
LabPsycho
LabPsycho Apr. 2 at 2:10 PM
$CNTX People should be amazed by the prescient post below....
0 · Reply
StockConsultant
StockConsultant Apr. 2 at 11:36 AM
$CNTX Context Therapeutics stock watch, nice trend with a pullback to 2.59 support area and bullish indicators
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 2 at 11:30 AM
$CNTX Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
0 · Reply
Fantastiqo
Fantastiqo Mar. 31 at 11:21 PM
$CNTX and $AEC this two been moving under the radar.
0 · Reply
hugoraciel
hugoraciel Mar. 31 at 1:01 AM
$CNTX Analyst coverage is mixed — one Strong Buy, seven Buy and one Sell — yielding a MarketBeat average rating of "Moderate Buy" and an average price target of $6.60, with select firms (Piper Sandler, Guggenheim) raising targets into the $5$7 range. So one fkn guys says SELLS and people panic? There 8 others that are saying to BUY!!!!
0 · Reply
Okaldirimj
Okaldirimj Mar. 31 at 1:00 AM
0 · Reply
hugoraciel
hugoraciel Mar. 31 at 12:59 AM
$CNTX did i fkn miss something today for the 11% fkn nose dive?
0 · Reply
elmono
elmono Mar. 30 at 8:53 PM
$CNTX I’ll be waiting a bit longer…new target 1.5 if we lose 2.3…..
1 · Reply
BioTechHealthX
BioTechHealthX Mar. 29 at 9:32 AM
$CNTX Context Therapeutics (NASDAQ: CNTX) is showing early signs of accumulation as interest builds in its oncology pipeline. With a low float and high volatility potential, this biotech stock could quickly shift into momentum territory when catalysts emerge. https://biotechhealthx.com/biotech-news/you-need-to-invest-in-context-therapeutics-cntx-before-its-too-late/
0 · Reply
gregwiseman
gregwiseman Mar. 29 at 1:08 AM
$CNTX i think the merger news should make the cntx to jump at 7$ in just one week,
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 28 at 5:00 AM
$CNTX RSI: 43.40, MACD: 0.0924 Vol: 0.28, MA20: 2.87, MA50: 2.46 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
LabPsycho
LabPsycho Mar. 27 at 8:18 PM
$CNTX @SpencerF IMO, they should have raised money about 2 weeks ago, and I think that if they try now, 1. the money for biotechs has dried up, 2. the trend in biotechs started downward about 5 weeks ago and 3. any potential private placment will really stick it to current investors: Unless, the phase 1 data of CTIM-76 knocks it out of the park and management is already getting a sniff of the data and that is why no offering yet. Overall, market trickling down could turn into a waterfall soon, esp biotech as this war (likely) drags on. Good luck.
0 · Reply
BioTechHealthX
BioTechHealthX Mar. 27 at 3:20 PM
$CAMP $CNTX $CTMX $GALT $IMUX Looking for high-growth biotech stocks? These micro-cap companies are showing strong momentum, active catalysts, and rising investor interest—making them top candidates for another surge. https://biotechhealthx.com/biotech-news/top-10-trending-micro-cap-biotech-stocks-to-watch-today/
0 · Reply
hugoraciel
hugoraciel Mar. 27 at 1:03 PM
$CNTX HAS A NEW $7 PT so MM brought it down
0 · Reply
SpencerF
SpencerF Mar. 26 at 7:59 PM
$CNTX does this confirm we should all dump? Or still a chance it could come back?
1 · Reply
LabPsycho
LabPsycho Mar. 26 at 12:37 PM
$CNTX I've been posting something along that line for a while now...BCAB has a lot of clinical data, and about to go in phase 3. CNTX could apply BCAB conditionally active biomolecule strategy to develop second generation CTIM-76 (conditionally active form). IMO, CNTX waited too long to do a money raise - those that did from last Oct- this early March got in before the pool of $$$ and market dried up
0 · Reply
winners3628
winners3628 Mar. 26 at 6:59 AM
$CNTX Merge with bcab or raise money now
0 · Reply
J1476
J1476 Mar. 25 at 9:30 PM
$CNTX someone wanted it cheaper. Back to 3 EOW
1 · Reply
Gaucho2021
Gaucho2021 Mar. 25 at 8:01 PM
$CNTX Does anyone have any info on what happened today? Reached $3.45 and it drops to $2.58 in 2 hrs!!
1 · Reply
VA_24
VA_24 Mar. 25 at 6:46 PM
$CNTX LabPsycho was right
0 · Reply